Cargando…
Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
HIV associated neurocognitive disorders (HAND) are the spectrum of cognitive impairments present in patients infected with human immunodeficiency virus type 1 (HIV-1). The number of patients affected with HAND ranges from 30 to 50% of HIV infected individuals and although the development of combinat...
Autores principales: | Omeragic, Amila, Kayode, Olanre, Hoque, Md Tozammel, Bendayan, Reina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350632/ https://www.ncbi.nlm.nih.gov/pubmed/32650790 http://dx.doi.org/10.1186/s12987-020-00204-5 |
Ejemplares similares
-
Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation
por: Omeragic, Amila, et al.
Publicado: (2017) -
Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
por: Huang, Chang, et al.
Publicado: (2023) -
Novel localization of folate transport systems in the murine central nervous system
por: Sangha, Vishal, et al.
Publicado: (2022) -
Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation
por: Ashraf, Tamima, et al.
Publicado: (2014) -
Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model
por: Omeragic, Amila, et al.
Publicado: (2019)